TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 94 filers reported holding TRINITY BIOTECH PLC in Q3 2014. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $9,705,000 | -24.9% | 554,244 | -21.6% | 0.39% | -22.6% |
| Q3 2014 | $12,915,000 | -15.7% | 706,909 | +6.2% | 0.50% | -17.1% |
| Q2 2014 | $15,326,000 | +39.2% | 665,462 | +46.5% | 0.60% | +28.8% |
| Q1 2014 | $11,007,000 | +42.4% | 454,264 | +47.8% | 0.47% | +38.3% |
| Q4 2013 | $7,728,000 | +22.8% | 307,412 | +6.3% | 0.34% | +2.1% |
| Q3 2013 | $6,292,000 | +97.4% | 289,162 | +52.9% | 0.33% | +98.8% |
| Q2 2013 | $3,187,000 | – | 189,162 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |